3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Osteomyelitis: new trials by email Literature Review of Osteomyelitis trials Research Report on Osteomyelitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis Bacteriophage Therapy, Placebo - Osteomyelitis, Diabetic Foot Osteomyelitis | Phase 2 | Terminated | Adaptive Phage Therapeutics, Inc. | 41 | 2021-11-24 | 2025-08-19 |
| Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis Dalbavancin, Standard of Care - Osteomyelitis | Phase 2 | Terminated | Allergan | 1 | 2017-05-15 | 2018-09-26 |
| Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis Intravenous Antibacterial Agent, Oral Antibacterial Agent - Osteomyelitis | Phase 2 | Terminated | Loyola University | 30 | 2014-03-19 | 2018-07-19 |
Bone Diseases (3) · Bone Diseases, Infectious (3) · Infections (3) · Musculoskeletal Diseases (3) · Endocrine System Diseases (2) · Glucose Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2)
Anti-Bacterial Agents (1) · Aztreonam (1) · Cefepime (1) · Ciprofloxacin (1) · Clindamycin (1) · Daptomycin (1) · Linezolid (1) · Meropenem (1) · Metronidazole (1) · Moxifloxacin (1) · Phage Therapy (1) · Piperacillin (1) · Piperacillin, Tazobactam Drug Combination (1) · Standard of Care (1) · Sulfamethoxazole (1)
Adaptive Phage Therapeutics, Inc. (1) · Allergan (1) · Loyola University (1)
United States (3)
Michael Pinzur, M.D. (1) · Nitsan Halevy, MD (1) · Urania Rappo, MD (1)